智通财经APP讯，凯莱英(06821)发布截至2025年12月31日止年度业绩，该集团取得收益约66.70亿元(人民币，下同)，同比增长14.91%;归属于上市公司股东的净利润约11.33亿元，同比增加19.35%;每股基本盈利3.16元。拟派付每10股普通股人民币13.00元(含税)。
公告称，公司秉承“做深”大客户，逐步延伸服务链。报告期内，来自大型制药公司收入人民币29.16亿元，同比增长8.36%;公司坚持“做广”中小客户，储备潜力项目。来自中小制药公司收入人民币37.55亿元，同比增长20.57%，收入来源呈现更为多元的趋势。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.